Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulfate for Neuroprotection in Traumatic Brain Injury
NCT04646876Phase 3Completed
- Start
- May 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in traumatic brain injury (TBI) comparing Magnesium Sulfate with Placebo (2 arms). Primary endpoint: Glasgow Outcome Scale at 2 months. Started May 2019; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT04646876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04646876.